- Home
- Publications
- Publication Search
- Publication Details
Title
Recombinant Zoster Vaccine (Shingrix®): A Review in Herpes Zoster
Authors
Keywords
-
Journal
DRUGS & AGING
Volume 35, Issue 12, Pages 1031-1040
Publisher
Springer Nature America, Inc
Online
2018-10-29
DOI
10.1007/s40266-018-0603-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines
- (2018) Kathleen L. Dooling et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention
- (2018) Nicolas Lecrenier et al. Expert Review of Vaccines
- Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
- (2018) Anthony L Cunningham et al. JOURNAL OF INFECTIOUS DISEASES
- Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older
- (2018) Desmond Curran et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials
- (2018) Martina Kovac et al. VACCINE
- Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial
- (2018) Céline Maréchal et al. VACCINE
- Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study
- (2018) Himal Lal et al. VACCINE
- Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States
- (2018) D. Curran et al. VACCINE
- Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000–2012
- (2018) Emad A. Yanni et al. BMJ Open
- Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults
- (2018) Tino F. Schwarz et al. Human Vaccines & Immunotherapeutics
- Th1 memory differentiates recombinant from live herpes zoster vaccines
- (2018) Myron J. Levin et al. JOURNAL OF CLINICAL INVESTIGATION
- Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old
- (2018) Desirée Van Oorschot et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older
- (2017) Tino F Schwarz et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine
- (2017) Katrijn Grupping et al. JOURNAL OF INFECTIOUS DISEASES
- A randomized lot-to-lot immunogenicity consistency study of the candidate zoster vaccine HZ/su
- (2017) Ana Strezova et al. VACCINE
- Herpes zoster prevention: A difficult problem to solve
- (2017) Susanna Esposito et al. VACCINE
- Vaccines for Herpes Zoster: A Systematic Review of Randomized Controlled Trials In Adults ≥50 Years of Age
- (2017) H Burnett et al. VALUE IN HEALTH
- Forecasting The Potential Public Health Impact of Herpes Zoster Vaccination In Italy
- (2017) DA van Oorschot et al. VALUE IN HEALTH
- A critical appraisal of ‘Shingrix’, a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus
- (2017) Tehmina Bharucha et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial
- (2017) Olivier Godeaux et al. Human Vaccines & Immunotherapeutics
- Assessment of the potential public health impact of Herpes Zoster vaccination in Germany
- (2017) Desmond Curran et al. Human Vaccines & Immunotherapeutics
- Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia
- (2016) Gillian M. Keating BIODRUGS
- Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
- (2016) Anthony L. Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults
- (2016) Roman Chlibek et al. VACCINE
- Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience
- (2016) Giovanni Gabutti et al. Human Vaccines & Immunotherapeutics
- Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly
- (2016) Peter Vink et al. Human Vaccines & Immunotherapeutics
- Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
- (2015) Himal Lal et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients
- (2014) E. A. Stadtmauer et al. BLOOD
- Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells
- (2014) Arnaud M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study
- (2014) Elchonon M. Berkowitz et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study
- (2014) Roman Chlibek et al. VACCINE
- Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age
- (2013) R. Chlibek et al. JOURNAL OF INFECTIOUS DISEASES
- Herpes Zoster
- (2013) Jeffrey I. Cohen NEW ENGLAND JOURNAL OF MEDICINE
- Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su)
- (2013) Himal Lal et al. Human Vaccines & Immunotherapeutics
- A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults
- (2012) Isabel Leroux-Roels et al. JOURNAL OF INFECTIOUS DISEASES
- Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice
- (2012) Najoua Dendouga et al. VACCINE
- Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine
- (2008) M. J. Levin et al. JOURNAL OF INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started